Cochlear Implants in Young Children With SSD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-71
SponsorUniversity of North Carolina, Chapel Hill

About this trial

The goal of this clinical trial is to investigate the safety and effectiveness of cochlear implantation in infants and toddlers with single-sided deafness.

The main questions it aims to answer are:

* Are cochlear implants an effective treatment of single-sided deafness in infants and toddlers? * Are cochlear implants a safe treatment for single-sided deafness in infants and toddlers?

Participants will receive a cochlear implant and be followed until they are five years old. During those five years, the investigators will program the device and monitor auditory development.

Children will be asked to:

* Undergo cochlear implantation * Wear their cochlear implant processor whenever they are awake. * Participate in traditional hearing tests * Participate in traditional hearing testing * Participate in localization testing * Participate in hearing in noise testing * Participate in word recognition testing * Participate in speech, language, and educational evaluations

The researchers will compare results to children with typical hearing in both ears and children with single-sided deafness who have not received an implant to observe any differences between the groups.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Provision of signed and dated parental permission form

Unaided residual hearing thresholds that yield a 3 frequency pure tone average (PTA; average at 500, 1000, and 2000 Hz) of ≥70 dB hearing loss (HL) in the ear to be implanted

Hearing thresholds in the contralateral ear of ≤20 dB HL (3 frequency PTA of 500, 1000, and 2000 Hz).

PEACH + parent questionnaire scores below the expected value for children who lack the requisite language to complete open-set word recognition testing or

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Cochlear Implant

    Device

    A cochlear implant is a surgically implanted device that provides access to sound in people cannot get enough access to sound for communication with traditional hearing aids.

Treatment groups

60 Participants
are divided into 3 treatment groups
Group A: Study GroupExperimental treatment 1 intervention
Group B: Typical Hearing Control Group (THCG)No intervention 0 interventions
Group C: Single-Sided Deafness Control Group (SSDCG)No intervention 0 interventions

Trial outcomes

Primary outcomes

1

Mean Difference in the Signal-to-Noise Ratio 50 (SNR-50) between the Study Group and SSD Control Group as Measured with the BKB-SIN at 5 Years of Age

Two ½ lists of the Bamford-Kowal-Bench Speech in Noise Test (BKB-SIN) will be presented in a single condition: speech in front and masker directed 90 degrees to the normal ear. The SNR-50 represents the signal-to-noise ratio required to perceive 50% of the sentence. A lower score is better. All participants will be 5 years old at the time of testing. The study group will use their cochlear implant in conjunction with the normal hearing ear. The SSD control group will use their normal hearing ear alone.

Time frame
5 years of age
2

Mean Difference in Localization Error Between the Study Group and the SSD Control group Measured at 5 Years of Age

Soundfield localization of 200-ms speech-shaped noise, presented from 11 speakers at 70 decibel (dB) sound pressure level (SPL) in a sound treated room. Overall root-mean-square (RMS) error is the difference between the sound source azimuth and the response azimuth and a lower score indicates more accurate localization of the sound source. All participants will be 5 years old at the time of testing. The study group will use their cochlear implant in conjunction with the normal hearing ear. The SSD control group will use their normal hearing ear alone.

Time frame
5 years of age

Secondary outcomes

1

Proportion of Procedural Related Adverse Events 6 months after Surgery

Procedural adverse events will be collected and reported as the proportion of subjects experiencing them.

Time frame
6 months after surgery
2

Proportion of Device-Related Adverse Events 6 Months after Surgery

Device related adverse events will be collected and reported as the proportion of subjects experiencing them.

Time frame
6 months after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.